Furthermore, the expression of the pro-inflammatory cytokines, IL-6 and IL-1β, was significantly reduced in the osthole-loaded GelMA group, indicating that GelMA could be a more effective drug delivery vehicle for osthole in the treatment of RA. This evidence concerns the gene IL1B and rheumatoid arthritis.